Its contribution to PCa progression aligns with findings in non-small cell lung cancer (NSCLC), where an inverse correlation has been observed between IL-38 expression and tumour differentiation (25), suggesting a pro-tumoral role for IL-38. This evidence concerns the gene IL1F10 and non-small cell lung carcinoma.